The Octane Medical Innovation Forum brings together industry experts, entrepreneurs, and investors for a two-day event in Irvine, CA. AI, of course, was part of the discourse, but panelists and entrepreneurs also had plenty to say about recent advancements in medtech, such as in robotics and neurovascular science, challenges in reimbursement, and more. Here is a collection of nuggets from the conversations on stage on 8 October.
Mark Dickinson, worldwide president Neurovascular, Johnson & Johnson MedTech: “Neurovascular is [a field] that’s really only about 20 years old in terms of the diseases that we’ve been treating and we really only scratched the surface about what we can treat in the